Challenges in Anesthesia Practice with Kratom
Keywords:
Kratom, Mitragynine, Cytochrome P-450, Drug interaction, Anesthesia practiceAbstract
Kratom, also known as Mitragyna speciosa, is a plant native to Southeast Asia. Its active ingredients, mitragynine and 7-hydroxymitragynine, affect the central nervous system in a manner similar to opioids; at low doses, kratom can increase work endurance and productivity, but at high doses it can have sedative effects and cause adverse reactions such as digestive and circulatory problems. Withdrawal symptoms, such as uncontrolled behavior, may occur if kratom consumption is stopped, but it is not known to lead to serious crimes. Kratom can also interfere with the liver’s metabolism of other drugs by inhibiting the cytochrome P-450 enzyme. As a result, drug interactions may occur. Despite being legalized by the Thai Traditional Medical Council, the use of kratom as alternative medicine should be monitored by healthcare professionals. Anesthesia personnel should be especially cautious with patients who have a history of kratom use as ones who have used other addictive drugs before, during, or after surgery.
Downloads
References
Veltri C, Grundmann O. Current perspectives on the impact of Kratom use. Substance abuse and rehabilitation. 2019; 10(1): 23-31.
Galbis-Reig D. A case report of kratom addiction and withdrawal. Wisconsin Medical Journal. 2016; 115(1): 49-52.
Swogger MT, Walsh Z. Kratom use and mental health: A systematic review. Drug Alcohol Depend. 2018; 183(1): 134-40.
Fluyau D, Revadigar N. Biochemical benefits, diagnosis, and clinical risks evaluation of kratom. Frontiers in psychiatry. 2017; 24(8): 62.
Stanciu C, Ahmed S, Gnanasegaram S, Gibson S, Penders T, Grundmann O, et al. Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature. The American Journal of Drug and Alcohol Abuse. 2022; 48(5): 509-28.
Wungsintaweekul J, Keawpradub N. Biology and Chemical Constituents of Kratom In: Chittrakarn S, editor. Summary of Kratom. 2th ed. Songkla: The Center for Studying the Problems of Epidemiology of the Faculty of Medicine Prince of Songkla University. 2020; 2(3): 17-24. (in Thai)
Sethi R, Hoang N, Ravishankar DA, McCracken M, Manzardo AM. Kratom (Mitragyna speciosa): friend or foe?. The primary care companion for CNS disorders. 2020; 22(1): 19.
Prozialeck WC, Jivan JK, Andurkar SV. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. Journal of Osteopathic Medicime-American Osteopathic Association. 2012; 112(12): 792-9.
Coe MA, Pillitterib JL, Sembowerb MA, Gerlachb KK, Henningfield JE. Kratom as a substitute for opioids: results from an online survey. Drug and Alcohol dependence. 2019; 202(1): 24-32.
Kucharik M, Gupta A, Averkiou P, Luck GR, Ross AS. Complicated postoperative course secondary to kratom withdrawal: a case report. Journal of Surgical Case Reports. 2019; 5(11): 309.
Singh D, Narayanan S, Vicknasingam B, Corazza O, Santacroce R, Roman-Urrestarazu A. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia. Human Psychopharmacology: Clinical and Experimental. 2017; 32(3): 1-6.
White CM. Pharmacologic and clinical assessment of kratom. American journal of health-system pharmacy. 2018; 75(5): 261-7.
Hassan Z, Muzaimi M, Navaratnam V, Yusoff NH, Suhaimi W, Vadivelu R, et al. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neuroscience & Biobehavioral Reviews. 2013; 37(2): 138-51.
Rungroung W. Kratom Toxicology. Thai Journal of Hospital Pharmacy. 2020; 30(2): 118-24. (in Thai)
Trakulsrichai S, Sathirakul K, Auparakkitanon S, Krongvorakul J, Sueajai J, Noumjad N, et al. Pharmacokinetics of mitragynine in man. Drug Des Devel Ther. 2015; 9(1): 2421-9.
Meireles V, Rosado T, Barroso M, Soares S, Gonçalves J, Luís Â, et al. Mitragyna speciosa: clinical, toxicological aspects and analysis in biological and non-biological samples. Medicines (Basel). 2019; 6(1): 35.
Hanapi NA, Ismail S, Mansor SM. Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities. Pharmacognosy Research. 2013; 5(4): 241-6.
Kamble SH, Sharma A, King TI, Berthold EC, León F, Meyer PKL, et al. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids. Toxicology Letters. 2020; 319(1): 148-54.
Sriwiriyajan S. Serious Drug Interactions from Kratom: Part 1. Thailand Narcotics Journal. 2020; 36(3): 6-9. (in Thai)
Amornyotin S. Kratom and Anesthesia. Thai J Anesthesiol. 2022; 48(4): 255-7. (in Thai)
Ramanathan S, Parthasarathy S, Murugaiyah V, Magosso E, Tan SC, Mansor SM, et al. Understanding the physicochemical properties of Mitragynine, a principal alkaloid of Mitragyna speciosa, for preclinical evaluation. Molecules 2015; 20(3): 4915–27.
Vicknasingam B, Narayanan S, Beng GT, Mansor SM. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy. 2010; 21(4): 283-8.
Matsumoto K, Horie S, Takayama H, Ishikawa H, Aimi N, Ponglux D, et al. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa. Life sciences. 2005; 78(1): 2–7.
Havemann-Reinecke U. P01-50-Kratom and alcohol dependence: Clinical symptoms, withdrawal treatment and pharmacological mechanisms - A case report. European Psychiatry. 2011; 26(2): 50.
Horie S, Koyama F, Takayama H, Ishikawa H, Aimi N, Ponglux D, et al. Indole alkaloids of a Thai medicinal herb, Mitragyna speciosa, that has opioid agonistic effect in guinea-pig ileum. Planta medica. 2005; 71(3): 231–6.
Watanabe K, Yano S, Horie S, Yamamoto LT. Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor. Life sciences. 1997; 60(12): 933–42.
Obeng S, Kamble SH, Reeves ME, Restrepo LF, Patel A, Behnke M, et al. Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids. Journal of Medicine Chemistry. 2020; 63(1): 433-9.
Warner ML, Kaufman NC, Grundmann O. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse. International Journal of Legal Medicine. 2016; 130(1): 127-38.
Purintrapiban J, Keawpradub N, Kansenalak S, Chittrakarn S, Janchawee B, Sawangjaroen K. Study on glucose transport in muscle cells by extracts from Mitragyna speciosa (Korth) and mitragynine. Natural Product Research. 2011; 25(15): 1379-87.
Demick DS, Lee TT, Summers AT, El-Mallakh RS. Kratom: A growing substance of abuse in the United States. Ann Clin Psychiatry. 2020; 32(4): 275-80.
Settle AG, Yang C. A Case of Severe Kratom Addiction Contributing to a Suicide Attempt. Cureus. 2022; 14(9): 1-5.
Prawatviteesuk A, Supan W, Sombood P, Vorasanon K, Vichitvejpaisal P. Cannabis, Kratom and Kariyat: Issues of Concern in Perianesthetic Care. Siriraj Medical Bulletin. 2022; 15(4): 266-74.
Lund E, Low A B, Allan J D, Puentes J A, Flynn D N. Anesthetic Challenges Posed by Heavy Kratom Users. Cureus. 2022; 14(3): 1-6.
Vermaire DJ, Skaer D, Tippets W. Kratom and General Anesthesia: A Case Report and Review of the Literature. A & A Practice. 2019; 12(4): 103-5.
Chittrakarn S, Keawpradub N, Sawangjaroen K, Kansenalak S, Janchawee B. The neuromuscular blockade produced by pure alkaloid, mitragynine and methanol extract of kratom leaves (Mitragyna speciosa Korth). Journal of Ethnopharmacology. 2010; 129(3): 344–9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of The Royal Thai Army Nurses
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความหรือข้อคิดเห็นใดใดที่ปรากฏในวารสารพยาบาลทหารบกเป็นวรรณกรรมของผู้เขียน ซึ่งบรรณาธิการหรือสมาคมพยาบาลทหารบก ไม่จำเป็นต้องเห็นด้วย
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารพยาบาลทหารบก
The ideas and opinions expressed in the Journal of The Royal Thai Army Nurses are those of the authors and not necessarily those
of the editor or Royal Thai Army Nurses Association.
